COMMUNIQUÉS West-GlobeNewswire

Shire plc : Result of AGM

24/04/2018 - 17:21

Result of the 2018 Annual General Meeting April 24, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that, at its Annual General Meeting held at Block 3, Miesian Plaza, 50-58 Baggot Street Lower, [...]

NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting

24/04/2018 - 17:00

WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported that it will present two scientific posters at the upcoming 2018 American Academy of Pain Medicine (AAPM) Annual [...]

Jellico Community Hospital Chooses Artifact Health Mobile App to Automate Physician Queries, Improve Patient Documentation and Recover Money for Appropriate Reimbursements

24/04/2018 - 16:20

BOULDER, Colo., April 24, 2018 (GLOBE NEWSWIRE) -- Artifact Health , which provides the first and only mobile app that streamlines the physician query process, announced today it has been selected by Jellico Community [...]

Theratechnologies to Seek Regulatory Approval of Trogarzo™ (ibalizumab) in Europe

24/04/2018 - 16:13

Based on Efficacy and Safety Data Used for FDA Approval MONTREAL, April 24, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) today announced that it will seek regulatory approval from the [...]

Theratechnologies déposera la demande d’approbation de Trogarzo(MC) (ibalizumab) en Europe

24/04/2018 - 16:13

Sur la base des données d’efficacité et d’innocuité ayant mené à l’approbation par la FDA MONTRÉAL, 24 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) a annoncé aujourd’hui qu’elle [...]

OpGen Highlights Acuitas® Analytical Validation Data for Rapidly Predicting Antibiotic Resistance Using Drug Resistance Gene Profiles at ECCMID

24/04/2018 - 16:07

DNA Sequencing prediction results and evaluation of Acuitas Resistome Test for infection control presented GAITHERSBURG, Md., April 24, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) today announced that it has [...]

Novo Nordisk A/S: Articles of Association for Novo Nordisk A/S

24/04/2018 - 15:50

Articles of Association for Novo Nordisk A/S Attachment Articles_of_association_UK_AGM2018.pdf

Novo Nordisk A/S - Reduction of the share capital

24/04/2018 - 15:47

Bagsværd, Denmark, 24 April 2018 - At Novo Nordisk's Annual General Meeting on 22 March 2018, it was decided to reduce the company's B share capital from DKK 392,512,800 to DKK 382,512,800 by cancellation of part of the [...]

Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran, Joins MyDx Executive Advisory Board

24/04/2018 - 15:45

Dr. Dreismann To Also Serve as Chairman of the Executive Advisory Board; Assist MyDx In Seeking Development Partners and Strategic Partners San Diego, CA, April 24, 2018 (GLOBE NEWSWIRE) -- MyDx, Inc. (OTC: MYDX), a [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

24/04/2018 - 15:31

FIT Biotech Oy Company release April 24, 2018 at 4:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Intrommune Therapeutics to Present at Eighth Annual BioNJ BioPartnering Conference

24/04/2018 - 15:27

New York, April 24, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a biopharmaceutical company developing a patient-friendly platform for the treatment of food allergies, announced today that it will be presenting at [...]

Progyny Launches “This is Infertility” Podcast

24/04/2018 - 15:00

New York City, April 24, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, announced today the launch of its podcast, “This is Infertility.” Each episode is hosted by a different voice [...]

Pediapharm to Present at Bloom Burton & Co. Healthcare Investor Conference

24/04/2018 - 15:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, April 24, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSXV:PDP) (OTCQB:PDDPF) has been [...]

Coherus BioSciences to Report First Quarter 2018 Financial Results on May 10th

24/04/2018 - 15:00

REDWOOD CITY, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that its first quarter 2018 financial results will be released after market close on Thursday, May 10, [...]

Tabula Rasa HealthCare Launches its Optimized Opioid Solution™ to Predict and Prevent Unintentional Opioid Abuse

24/04/2018 - 15:00

BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- AMCP Annual Meeting - Tabula Rasa HealthCare, Inc., (TRHC) (NASDAQ: TRHC ), a healthcare technology company advancing the field of medication safety, today announced its [...]

Helsinn Group to Present a Poster at Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2018

24/04/2018 - 14:45

Helsinn Group to Present a Poster at Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2018 Poster: Budget Impact of Fixed Combination NEPA for the Prevention of Chemotherapy Induced Nausea and Vomiting Lugano, [...]

Alder BioPharmaceuticals® Presents New 12-Month Data of Eptinezumab in PROMISE 1 Phase 3 Trial Showing Long-Term Reduction in Episodic Migraine

24/04/2018 - 14:30

- Data presented at AAN Annual Meeting demonstrate eptinezumab further reduces migraine risk following the third and fourth quarterly infusions - More than 50% of patients achieved a 75% reduction or greater of migraine [...]

Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series™ Products That Provide Automated, Closed System Cellular Processing

24/04/2018 - 14:30

RANCHO CORDOVA, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that [...]

Yield10 Bioscience Announces Plans for its 2018 Field Test Program

24/04/2018 - 14:30

WOBURN, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]